Duchenne muscular dystrophy
Michael H. Brooke, Cynthia L. Arfken, Robert C. Griggs(University of Rochester), Gerald M. Fenichel(Vanderbilt University), Kenneth K. Kaiser, Stephen Mandel(Washington University in St. Louis), L. Signore(The Ohio State University), J. Philip Miller(University of Minnesota), Justin Robison(Vanderbilt University), Richard T. Moxley(Unknown), Jerry R. Mendell(Nationwide Children's Hospital), Julaine Florence, Jeanine Schierbecker, Wendy King(The Ohio State University), S. Pandya(Strong Memorial Hospital), Beverly Gilder
Cited by 351
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Clinical trial in duchenne dystrophy. I. The design of the protocol
|Muscle & Nerve|1981|563
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1995|522